Global Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Forecast 2024-2030- Product Image

Sale

Global Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Forecast 2024-2030

Report
197 Pages
March 2024
Region: Global
360iResearch™
ID: 5674447

UP TO €846EUR$875USD£722GBP OFF until Dec 31^st 2024

The Particle Therapy Market size was estimated at USD 772.41 million in 2023, USD 831.50 million in 2024, and is expected to grow at a CAGR of 7.94% to reach USD 1,318.87 million by 2030.The particle therapy forms a specific segment of the broader therapeutical technology. Primarily, it focuses on the global commercialization, distribution, and application of particle therapy technologies. Particle therapy utilizes charged and uncharged particles, such as protons and neutrons, within a controlled environment to target and eliminate cancer cells inside a patient's body. The effectiveness of this therapy in ensuring precision mainly drives market demand and growth. The increasing need for advanced therapies in cancer treatment and the rising adoption of particle therapy in clinical trials, fast, non-invasive, and painless procedures significantly contribute to driving this market growth. In contrast, limited insurance coverage for particle therapy and risk associated with particle therapy radiation exposure limits their utilization and penetrates the market growth. However, several vendors are developing more advanced and compact particle therapy systems and focusing on enhancing precision and minimizing potential side effects. Moreover, ongoing proton therapy research programs and technological advancements in charged-particle therapy are creating a myriad of opportunities for particle therapy expansion.

Regional Insights

In America, the need for particle therapy has seen consistent growth. Technology innovation is frequent and heavily backed by both private and public organizations. This region holds the most significant market share due to extensive research activities and the rise of numerous startups funded by investors targeting therapy innovation. In the EMEA region, Europe exhibits formidable growth in particle therapy primarily due to the rising incidences of various cancer types and a growing elderly population at risk. Moreover, increased funding in healthcare from various governments and organizations, coupled with well-established healthcare facilities, allows for broader adoption of the technique. Middle Eastern and African countries also show promising growth, mainly due to rising healthcare expenditure and increased efforts to enhance healthcare infrastructure. In the APAC region, several economies are leading in adopting particle therapy for cancer treatment. Factors contributing to such progress include the increasing prevalence of cancer, rapid urbanization, and continually improving economic conditions. APAC offers a vast population base, which, combined with improving healthcare infrastructures and increasing government funding for cancer research and treatment, presents APAC as a fast-growing market for particle therapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Particle Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Particle Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd.

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapy Type
- Heavy Ion Therapy
- Proton Therapy
Component
- Product
  - Cyclotrons
  - Synchrocyclotrons
  - Synchrotrons
- Service
Configuration
- Multi-room System
- Single-room System
Cancer Type
- Breast Cancer
- Head & Neck Cancer
- Lung Cancer
- Pediatric Cancer
- Prostate Cancer
End-User
- Ambulatory Surgery Centers
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Particle Therapy Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Particle Therapy Market?
What are the technology trends and regulatory frameworks in the Particle Therapy Market?
What is the market share of the leading vendors in the Particle Therapy Market?
Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Particle Therapy Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for advanced therapies in cancer treatment
5.1.1.2. Rise in adoption of particle therapy in clinical trials
5.1.1.3. Growing number of particle therapy centers worldwide
5.1.2. Restraints
5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
5.1.3. Opportunities
5.1.3.1. Ongoing proton therapy research programs
5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
5.1.4. Challenges
5.1.4.1. Risk associated with the particle therapy radiation exposure
5.2. Market Segmentation Analysis
5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Particle Therapy Market, by Therapy Type

6.1. Introduction
6.2. Heavy Ion Therapy
6.3. Proton Therapy

7. Particle Therapy Market, by Component

7.1. Introduction
7.2. Product
7.3.1. Cyclotrons
7.3.2. Synchrocyclotrons
7.3.3. Synchrotrons
7.3. Service

8. Particle Therapy Market, by Configuration

8.1. Introduction
8.2. Multi-room System
8.3. Single-room System

9. Particle Therapy Market, by Cancer Type

9.1. Introduction
9.2. Breast Cancer
9.3. Head & Neck Cancer
9.4. Lung Cancer
9.5. Pediatric Cancer
9.6. Prostate Cancer

10. Particle Therapy Market, by End-User

10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals & Clinics

11. Americas Particle Therapy Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Particle Therapy Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Particle Therapy Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Agreement, Collaboration, & Partnership
14.3.1.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
14.3.2. Investment & Funding
14.3.2.1. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
14.3.3. Award, Recognition, & Expansion
14.3.3.1. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Advanced Oncotherapy plc
15.1.2. B dot Medical Inc.
15.1.3. Best Particle Therapy, Inc.
15.1.4. BioSig Technologies Inc.
15.1.5. Covenant Health
15.1.6. Danfysik A/S
15.1.7. Elekta AB
15.1.8. Hitachi, Ltd.
15.1.9. IBA International
15.1.10. Koninklijke Philips N.V.
15.1.11. Mevion Medical Systems
15.1.12. Mitsubishi Electric Corporation
15.1.13. New Mexico Cancer Center
15.1.14. Optivus Proton Therapy, Inc.
15.1.15. P-Cure Ltd
15.1.16. ProTom International
15.1.17. Provision Healthcare, LLC
15.1.18. PTW Freiburg GmbH
15.1.19. SAH Global LLC
15.1.20. Shanghai APACTRON Particle Equipment Co., Ltd.
15.1.21. Siemens Healthineers GmbH
15.1.22. Stantec Inc.
15.1.23. Sumitomo Heavy Industries, Ltd.
15.1.24. Toshiba Medical Systems Corporation
15.1.25. Xstrahl Ltd.
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
FIGURE 7. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 8. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 10. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2030 (%)
FIGURE 12. PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 14. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 9. PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 16. PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 19. PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 79. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 82. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 83. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 88. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 89. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 97. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 100. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 133. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 136. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 158. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 170. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. ITALY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. ITALY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 191. ITALY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 206. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. NORWAY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 209. NORWAY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 212. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. POLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. POLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 215. POLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 219. QATAR PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. QATAR PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 221. QATAR PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. SPAIN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 278. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 279. PARTICLE THERAPY MARKET LICENSE & PRICING

Companies Mentioned

Advanced Oncotherapy plc
B dot Medical Inc.
Best Particle Therapy, Inc.
BioSig Technologies Inc.
Covenant Health
Danfysik A/S
Elekta AB
Hitachi, Ltd.
IBA International
Koninklijke Philips N.V.
Mevion Medical Systems
Mitsubishi Electric Corporation
New Mexico Cancer Center
Optivus Proton Therapy, Inc.
P-Cure Ltd
ProTom International
Provision Healthcare, LLC
PTW Freiburg GmbH
SAH Global LLC
Shanghai APACTRON Particle Equipment Co., Ltd.
Siemens Healthineers GmbH
Stantec Inc.
Sumitomo Heavy Industries, Ltd.
Toshiba Medical Systems Corporation
Xstrahl Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 831.5 Million
Forecasted Market Value ( USD ) by 2030	$ 1318.87 Million
Compound Annual Growth Rate	7.9%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,784GBP €3625EUR$3,749USD£3,093GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,526GBP €4592EUR$4,749USD£3,918GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5003EUR$5,174USD£4,269GBP €5559EUR$5,749USD£4,743GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5873EUR$6,074USD£5,011GBP €6526EUR$6,749USD£5,568GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,496GBP €8459EUR$8,749USD£7,218GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Particle Therapy Global Market Report 2024

Particle Therapy - Global Strategic Business Report

Global Particle Therapy Market: Focus on Products and Services, Application, Cancer Type, Type, System, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033

Global Particle Therapy Market Report and Forecast 2024-2032

Particle Therapy System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type